<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04785105</url>
  </required_header>
  <id_info>
    <org_study_id>SMA_2020</org_study_id>
    <nct_id>NCT04785105</nct_id>
  </id_info>
  <brief_title>Natural History of Asymptomatic Superior Mesenteric Arterial Stenosis.</brief_title>
  <official_title>Natural History of Asymptomatic Superior Mesenteric Arterial Stenosis Depends on Celiac and Inferior Mesenteric Arteries Status.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to evaluate asymptomatic superior mesenteric artery (SMA) stenosis&#xD;
      prognosis according to the presence of coeliac artery (CA) and/or inferior mesenteric artery&#xD;
      (IMA) associated stenosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: The benefit of preventive treatment for SMA stenosis remains uncertain. The&#xD;
      latest guidelines remain unclear given the lack of data in the literature.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Development of mesenteric disease defined as acute mesenteric ischemia or chronic mesenteric ischemia.</measure>
    <time_frame>4 years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">77</enrollment>
  <condition>Stenosis</condition>
  <arm_group>
    <arm_group_label>patient with isolated SMA stenosis</arm_group_label>
    <description>patient with isolated SMA stenosis on initial scanner</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patient with both SMA stenosis and CA or/and IMA stenosis</arm_group_label>
    <description>patient with both SMA stenosis and CA or/and IMA stenosis on initial scanner</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>patient with both SMA stenosis and CA or/and IMA stenosis</arm_group_label>
    <arm_group_label>patient with isolated SMA stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  patients with isolated &gt;70% SMA stenosis&#xD;
&#xD;
          -  patients with both SMA stenosis and CA or/and IMA &gt;70% stenosis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  the presence of coeliac artery (CA) and/or inferior mesenteric artery (IMA) associated&#xD;
             stenosis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Groupement Hospitalier Est</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 22, 2020</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2021</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SMA</keyword>
  <keyword>Stenosis</keyword>
  <keyword>Stenosis on scanner</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

